A sample of the posters to be presented at the Liquid Biopsy Summit include:
Anchor Molecular, Inc.
Characterization of DNA-Free Plasma and Its Usage as True-Plasma Based Quality Control Standards for ctDNA Testing
Biomatrica, Inc.
The Impact of Preanalytical Variables on Cell-Free DNA and Circulating Tumor Cells
Bioo Scientific, a PerkinElmer company
A Dependable Automated Workflow for Cell-Free DNA Extraction and Downstream NGS Library Preparation
Expedeon
TruePrime™ Liquid Biopsy: The First Tool to Amplify Cell-Free DNA
Hitachi Ltd.
Digital PCR with Melting Curve Analysis for KRAS Genotyping
Mayo Clinic
Circulating Tumor DNA in Endometrial Cancer: Individualized Tumor DNA Testing
Mikro Biyosistemler Electronics, Inc.
Development of EpCAM Sensitive Surface Functionalization Strategy for CTC Capture in Microfluidic Channels
National Tsing Hua University
Applying Circulating Biomarkers Discovery from Blood Biopsy in Chinese Medicine
Promega Corporation
Automated miRNA Purification from Plasma, Serum or Exosomes
Shenzhen Peoples Hospital
Isolation and Expansion the Circulating Tumor Cells from Patients' Peripheral Blood In Vitro
Taipei Medical University
Anti-Proliferative Effects of ZFP36L1 and ZFP36L2 on the Human Colorectal Cancer Cells
Thermo Fisher Scientific
An Efficient NGS Workflow for Liquid Biopsy Research Using a Comprehensive Assay - Oncomine™ Pan-Cancer Cell-Free Assay
University of Hawaii Cancer Center
Circulating Cell-Free DNA Characteristics of Pre-Treatment Plasma/Serum Samples from Cancer Patients